# Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease

> **NCT04519671** · PHASE1,PHASE2 · TERMINATED · sponsor: **Anthony Lembo** · enrollment: 25 (actual)

## Conditions studied

- Perianal Crohn Disease
- Perianal Fistula
- Crohn Disease

## Interventions

- **DRUG:** Mesenchymal Stem Cells
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04519671
- **Lead sponsor:** Anthony Lembo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-19
- **Primary completion:** 2022-07-12
- **Final completion:** 2022-11-16
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** PI left Cleveland Clinic
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04519671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04519671, "Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04519671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*